Antidepressants Flashcards
Amitriptyline
Class
MOA
- Tricyclic antidepressant (TCA)
- CNS modulation of 5HT (strong effects) & NEpi (moderate effects) – increasing levels of both
Serotonin-NEpi reuptake inhibitor
Amitriptyline
- Indications
- char
- Major depression, bipolar disorder, migraine & tension HA, chronic pain
2.PO, IM
Usually taken at bedtime to minimize drowsiness/dizziness
Discontinuation syndrome: stopping tx abruptly causes withdrawal-like sx (nausea, HA, dizziness, lethargy, flu-like sx)
Amitriptyline
side effects
Dizziness, marked drowsiness, anticholinergic effects (dry mouth, constipation, urinary hesitancy, blurred vision)
Remeron
Class
Indications
MOA
- Tetracyclic antidepressant
- depression
- 5-HT2 & 5-HT3 receptor antagonist
Also antagonizes H1 & peripheral alpha-1 adrenergic receptors
Remeron Characterisitcs
Sedation, weight gain, increased appetite, dizziness, nausea, dry mouth, edema, increased cholesterol
Rare: agranulocytosis, neutropenia, NMS or serotonin syndrome, may lower seizure threshold
Remeron CI
characterisitics
CI: EtOH, benzos, other CNS depressants, MAOIs
Monitor cholesterol, CBC, suicidal ideation
Trazodone
c;ass
Indications
MOA
- Tetracyclic antidepressant
- Major depressive disorder, anxiety, panic disorder, insomnia
Many off-label uses
-Serotonin reuptake inhibitor & partial antagonist
Decreased 5HT reuptake at presynaptic cleft increased 5HT in synapse & increased 5HT available at post-synaptic receptor sites
Trazadone Side effects
Sedation, orthostatic hypotension, fatigue, possible cardiac dysrhythmias, possible mania w/ bipolar disorder, increased suicide risk
Overdose: monitor for hypotension
Fluoxetine
class
indications
moa
- SSRI
- Major depressive disorder, OCD, bulimia, panic disorder
- Decreased serotonin reuptake at presynaptic cleft = increased 5HT levels in synapse & Increased 5HT available at post-synaptic receptor sites
Fluoxetine
SE
Sexual dysfunction (lack of interest, impotency, anorgasmia) Serotonin syndrome: fever, agitation, diarrhea, elevated blood pressure
Fluoxetine
Char
PO
½ life: 48-72 hours – why risk of serotonin syndrome
Caution w/ NSAID use – increased risk of GI bleeding & NSAIDs may interfere & reduce efficiency of SSRIs
Duloxetine
class
MOA
Indications
- SNRI
- Major depressive disorder, generalized anxiety disorder, painful peripheral neuropathy, fibromyalgia, OA, lumbago
- Inhibits reuptake of 5HT & NEpi
Duloxetine SE
CHar
HA, somnolence, fatigue, nausea, xerostomia, insomnia, erectile dysfunction
CI: heavy EtOH or chronic liver disease – causes elevation of liver enzymes which can -> acute hepatitis
Buproprion
Class
Ind
MOA
- NDRI
- Major depression, bipolar disorder, ADD, smoking cessation (but called Zyban)
- Blocks NEpi & DA reuptake = increased pool of NT in synaptic cleft
Buproprion
SE
Char
HA, insomnia, xerostomia, restlessness, tremors, agitation, anxiety, sweating, dizziness
Takes 5-7 days to reach steady-state blood level